These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 20225996

  • 1. Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting.
    Malessa R, Gendolla A, Steinberg B, Schmitt L, Bornhoevd K, Djelani M, Schäuble B, TOPMAT-MIG-3004 investigators.
    Curr Med Res Opin; 2010 May; 26(5):1119-29. PubMed ID: 20225996
    [Abstract] [Full Text] [Related]

  • 2. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G, Delbrück A, Schulze L, Kademann B, Bornhoevd K, Schäfer S, Schäuble B, TOPMAT-MIG-4009 investigators.
    Headache; 2009 May; 49(10):1454-65. PubMed ID: 19804392
    [Abstract] [Full Text] [Related]

  • 3. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 4. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 5. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Mar; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 8. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 9. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 10. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Dec; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 11. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group.
    JAMA; 2004 Feb 25; 291(8):965-73. PubMed ID: 14982912
    [Abstract] [Full Text] [Related]

  • 12. Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting.
    Nelles G, Schmitt L, Humbert T, Becker V, Sandow P, Bornhoevd K, Fritzsche D, Schäuble B, TOPMATMIG-0001 investigators.
    J Headache Pain; 2010 Feb 25; 11(1):33-44. PubMed ID: 19894100
    [Abstract] [Full Text] [Related]

  • 13. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.
    Cephalalgia; 2011 Jan 25; 31(1):18-30. PubMed ID: 20974598
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul 25; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 15. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun 25; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

  • 16. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis.
    Luo N, Di W, Zhang A, Wang Y, Ding M, Qi W, Zhu Y, Massing MW, Fang Y.
    Pain Med; 2012 Jan 25; 13(1):80-6. PubMed ID: 22233396
    [Abstract] [Full Text] [Related]

  • 17. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep 25; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 18. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV, Jevoux CC.
    Headache; 2011 Apr 25; 51(4):554-8. PubMed ID: 21457240
    [Abstract] [Full Text] [Related]

  • 19. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK, Voirin J, Farmer K, Browning R, Beach ME, Tarrasch J.
    Headache; 2012 May 25; 52(5):749-64. PubMed ID: 22188311
    [Abstract] [Full Text] [Related]

  • 20. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT, Jaffri SF.
    Headache; 2009 May 25; 49(10):1466-78. PubMed ID: 19912346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.